Maravai LifeSciences (NASDAQ:MRVI) just disclosed its Q4 earnings on Wednesday, February 25, 2026 at 04:05 PM.

Here's a brief overview of the earnings report.

Earnings

Maravai LifeSciences beat estimated earnings by 50.0%, reporting an EPS of $-0.04 versus an estimate of $-0.08.

Revenue was down $6.69 million from the same period last year.

Overview of Past Earnings

The company missed on EPS by $0.0 in the previous quarter, leading to a 0.69% drop share price change the next day.

Here's a look at Maravai LifeSciences's past performance:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	-0.08	-0.08	-0.07	-0.04
EPS Actual	-0.08	-0.08	-0.08	-0.06
Revenue Estimate	49.88M	47.81M	44.01M	57.79M
Revenue Actual	41.63M	47.40M	46.85M	56.56M

To track all earnings releases for Maravai LifeSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.